86 related articles for article (PubMed ID: 23464435)
1. Association of human epidermal growth factor receptor-2 expression and clinicopathological findings in patients with colorectal cancer.
Karaca H; Deniz K; Berk V; Inanc M; Ozkan M
Asian Pac J Cancer Prev; 2012; 13(12):6221-5. PubMed ID: 23464435
[TBL] [Abstract][Full Text] [Related]
2. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
Yao YF; Du CZ; Chen N; Chen P; Gu J
Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
[TBL] [Abstract][Full Text] [Related]
3. HER-2 incidence in gastric cancer, its association with prognosis and clinicopathological parameters.
Uprak TK; Attaallah W; Çelikel ÇA; Ayrancı G; Yeğen C
Ulus Cerrahi Derg; 2015; 31(4):207-13. PubMed ID: 26668528
[TBL] [Abstract][Full Text] [Related]
4. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
Wu SW; Ma CC; Li WH
Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
[TBL] [Abstract][Full Text] [Related]
5. Changing frequency of equivocal HER-2/neu scores and factors predictive of negative HER 2/neu fluorescent in situ hybridisation in invasive carcinomas of the breast.
Boulos F; Farra CG; Saad Aldin EM; Masaad C; Hassoun Y; Fedda F; Doumiati H; Tawil AN; Nasser Z; Nahleh Z; Tfayli A
J Clin Pathol; 2014 Mar; 67(3):204-9. PubMed ID: 24108431
[TBL] [Abstract][Full Text] [Related]
6. HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.
Park DI; Kang MS; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Han WK; Kim H; Ryu SH; Sepulveda AR
Int J Colorectal Dis; 2007 May; 22(5):491-7. PubMed ID: 16947041
[TBL] [Abstract][Full Text] [Related]
7. Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from Turkey.
Budakoglu B; Altundag K; Aksoy S; Kaplan MA; Ozdemir NY; Berk V; Ozkan M; Algin E; Kandemir N; Dogu GG; Harputluoglu H; Arslan UY; Coskun U; Isikdogan A; Oksuzoglu B
J BUON; 2014; 19(4):872-8. PubMed ID: 25536589
[TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor receptor (EGFR) in colorectal cancer: An immunohistochemical study.
Ben Brahim E; Ayari I; Jouini R; Atafi S; Koubaa W; Elloumi H; Chadli A
Arab J Gastroenterol; 2018 Sep; 19(3):121-124. PubMed ID: 30243897
[TBL] [Abstract][Full Text] [Related]
9. Correlation of human epidermal growth factor receptor protein expression and colorectal cancer.
Yang WJ; Shen XJ; Ma XX; Tan ZG; Song Y; Guo YT; Yuan M
World J Gastroenterol; 2015 Jul; 21(28):8687-96. PubMed ID: 26229411
[TBL] [Abstract][Full Text] [Related]
10. HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
Harbeck N; Ross JS; Yurdseven S; Dettmar P; Pölcher M; Kuhn W; Ulm K; Graeff H; Schmitt M
Int J Oncol; 1999 Apr; 14(4):663-71. PubMed ID: 10087312
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
[TBL] [Abstract][Full Text] [Related]
12. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.
Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM
Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345
[TBL] [Abstract][Full Text] [Related]
13. [Detection of human epidermal growth factor receptor 2 gene in invasive breast cancer by fluorescence in situ hybridization and research of its association with tumor characteristics].
Su J; Yang Y; Ma XL; You JF; DU J; Liu JY; Zheng J
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):199-203. PubMed ID: 21503112
[TBL] [Abstract][Full Text] [Related]
14. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
15. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 Inhibits Proliferation, Migration, and Invasion of Human Colorectal Cancer Cells by Suppressing Phosphorylation of Epidermal Growth Factor Receptor.
Yang J; Zhu T; Zhao R; Gao D; Cui Y; Wang K; Guo Y
Med Sci Monit; 2018 Jan; 24():332-341. PubMed ID: 29339715
[TBL] [Abstract][Full Text] [Related]
17. Human Epidermal Growth Factor Receptor Expression in Colorectal Cancer and Its Relationship with Clinicopathological Characteristics.
Torabizadeh Z; Nosrati A; Tahvildari S
Middle East J Dig Dis; 2016 Jan; 8(1):24-30. PubMed ID: 26933478
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy.
Huang MY; Tsai HL; Lin CH; Huang CW; Ma CJ; Huang CM; Chai CY; Wang JY
J Surg Oncol; 2013 Dec; 108(7):457-64. PubMed ID: 23996617
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing.
Schmidt M; Lewark B; Kohlschmidt N; Glawatz C; Steiner E; Tanner B; Pilch H; Weikel W; Kölbl H; Lehr HA
Breast Cancer Res; 2005; 7(2):R256-66. PubMed ID: 15743506
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.
Khan AJ; King BL; Smith BD; Smith GL; DiGiovanna MP; Carter D; Haffty BG
Clin Cancer Res; 2002 Feb; 8(2):540-8. PubMed ID: 11839675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
